SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Zhejiang Hisun Pharmaceutical to Acquire Rights to Rigerna Therapeutics Platform, Product

600267

Story updates

11:17:34 AM UTC
SquawkNews
ZHEJIANG HISUN PHARMACEUTICAL SAYS UPFRONT PAYMENT 10 MLN YUAN, DEVELOPMENT MILESTONE PAYMENTS UP TO